High-throughput quantification of splicing isoforms

RNA

Volumn 16, Issue 2, 2010, Pages 442-449

  Brosseau, Jean Philippe ^a   Lucier, Jean Francxois ^a   Lapointe, Elvy ^a   Durand, Mathieu ^a   Gendron, Daniel ^a   Gervais Bird, Julien ^a   Tremblay, Karine ^a   Perreault, Jean Pierre ^a   Elela, Sherif Abou ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Alternative splicing; mRNA detection; Primer design; Quantitative real time PCR

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; PARAFFIN; PRIMER RNA;

ACCURACY; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER TISSUE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY; OVARY CANCER; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION;

ALTERNATIVE SPLICING; BASE SEQUENCE; DNA PRIMERS; HUMANS; POLYMERASE CHAIN REACTION; RNA SPLICE SITES; RNA, MESSENGER;

EID: 75149179617     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.1877010     Document Type: Article

References (31)

1. Abrahamsen HN, Steiniche T, Nexo E, Hamilton-Dutoit SJ, Sorensen BS. 2003. Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptasepolymerase chain reaction: A methodological study on lymph nodes from melanoma patients. J Mol Diagn 5: 34-41.
2. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
3. Antonov J, Goldstein DR, Oberli A, Baltzer A, Pirotta M, Fleischmann A, Altermatt HJ, Jaggi R. 2005. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 85: 1040-1050.
4. Ayyadevara S, Thaden JJ, Shmookler Reis RJ. 2000. Discrimination of primer 39-nucleotide mismatch by Taq DNA polymerase during polymerase chain reaction. Anal Biochem 284: 11-18.
5. Bracco L, Throo E, Cochet O, Einstein R, Maurier F. 2006. Methods and platforms for the quantification of splice variants' expression. Prog Mol Subcell Biol 44: 1-25.
6. Calarco JA, Xing Y, Caceres M, Calarco JP, Xiao X, Pan Q, Lee C, Preuss TM, Blencowe BJ. 2007. Global analysis of alternative splicing differences between humans and chimpanzees. Genes & Dev 21: 2963-2975.
7. Castle JC, Zhang C, Shah JK, Kulkarni AV, Kalsotra A, Cooper TA, Johnson JM. 2008. Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat Genet 40: 1416-1425.
8. Cronin M, Pho M, Dutta D, Stephans JC, Shak S, Kiefer MC, Esteban JM, Baker JB. 2004. Measurement of gene expression in archival paraffin-embedded tissues: Development and performance of a 92-gene reverse transcriptase- polymerase chain reaction assay. Am J Pathol 164: 35-42.
9. Farragher SM, Tanney A, Kennedy RD, Paul Harkin D. 2008. RNA expression analysis from formalin fixed paraffin embedded tissues. Histochem Cell Biol 130: 435-445.
10. Foissac S, Sammeth M. 2007. ASTALAVISTA: Dynamic and flexible analysis of alternative splicing events in custom gene datasets. Nucleic Acids Res 35: W297-W299.
11. Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Gervais-Bird J, Madden R, Paquet ER, Koh C, Venables JP, Prinos P, et al. 2008. Multiple alternative splicing markers for ovarian cancer. Cancer Res 68: 657-663.
12. Koch I, Slotta-Huspenina J, Hollweck R, Anastasov N, Hofler H, Quintanilla-Martinez L, Fend F. 2006. Real-time quantitative RTPCR shows variable, assay-dependent sensitivity to formalin fixation: Implications for direct comparison of transcript levels in paraffin-embedded tissues. Diagn Mol Pathol 15: 149-156.
13. Morrison TB, Weis JJ, Wittwer CT. 1998. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24: 954-962.
14. Nagao K, Togawa N, Fujii K, Uchikawa H, Kohno Y, Yamada M, Miyashita T. 2005. Detecting tissue-specific alternative splicing and disease-associated aberrant splicing of the PTCH gene with exon junction microarrays. Hum Mol Genet 14: 3379-3388.
15. Ni JZ, Grate L, Donohue JP, Preston C, Nobida N, O'Brien G, Shiue L, Clark TA, Blume JE, Ares M Jr. 2007. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes & Dev 21: 708-718.
16. Nolan T, Hands RE, Bustin SA. 2006a. Quantification of mRNA using real-time RT-PCR. Nat Protoc 1: 1559-1582.
17. Nolan T, Hands RE, Ogunkolade W, Bustin SA. 2006b. SPUD: A quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. Anal Biochem 351: 308-310.
18. Oberli A, Popovici V, Delorenzi M, Baltzer A, Antonov J, Matthey S, Aebi S, Altermatt HJ, Jaggi R. 2008. Expression profiling with RNA from formalin-fixed, paraffin-embedded material. BMC Med Genomics 1: 9. doi: 10.1186/1755-8794-1-9.
19. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413-1415.
20. Pruitt KD, Tatusova T, Maglott DR. 2007. NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 35: D61-D65.
21. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
22. Tazi J, Bakkour N, Stamm S. 2009. Alternative splicing and disease. Biochim Biophys Acta 1792: 14-26.
23. Thierry-Mieg D, Thierry-Mieg J. 2006. AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 Suppl 1: S12.1-14.
24. Vandenbroucke II, Vandesompele J, Paepe AD, Messiaen L. 2001. Quantification of splice variants using real-time PCR. Nucleic Acids Res 29: E68-8.
25. Venables JP. 2006. Alternative splicing in cancer. Transworld Research Network, Kerala, India.
26. Venables JP, Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Koh C, Gervais-Bird J, Lapointe E, Froehlich U, Durand M, et al. 2008. Identification of alternative splicing markers for breast cancer. Cancer Res 68: 9525-9531.
27. Walton HS, Gebhardt FM, Innes DJ, Dodd PR. 2007. Analysis of multiple exon-skipping mRNA splice variants using SYBR Green real-time RT-PCR. J Neurosci Methods 160: 294-301.
28. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
29. Wellmann S, Taube T, Paal K, Graf V, Einsiedel H, Geilen W, Seifert G, Eckert C, Henze G, Seeger K. 2001. Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology. Clin Chem 47: 654-660.
30. Williams DM, Koduri S, Li Z, Hankins WD, Poola I. 1999. Primer design strategies for the targeted amplification of alternatively spliced molecules. Anal Biochem 271: 194-197.
31. Yang D, Le J. 1994. Targeted amplification of alternatively spliced transcripts of major histocompatibility complex class I heavy chain. J Immunol Methods 176: 265-270.